Skip to main content
. 2020 Jul 30;10:12809. doi: 10.1038/s41598-020-69331-1

Table 5.

Details of the questionnaires.

Section Item
I. General items Sex Male/female
Age Years
Retired Yes/no
II. Disease specific items Liver tumor Primary
Comorbidities Secondary
III. Therapy related items Medical consultant
Current therapy
Regular medical follow-up Yes/no
Redo SRFA Yes/no
Fear of repeat SRFA Yes/no
Physical state after SRFA Better/worse/equal
IV. Symptoms after SRFA Pain Scale, duration
Fever Yes/no, duration
Poor wound healing Yes/no
Digestive disturbances Yes/no, duration
Reflux Yes/no, duration
Night sweats Yes/no, duration
Nausea/vomiting Yes/no, duration
Lack of appetite Yes/no, duration
Weakness Yes/no, duration
V. Other treatments (not SRFA) with comparison Treatment TACE, CTX, HR
Direct comparison of treatments Side-effects
Physical stress
Impairment
Preference
VI. Suggestions for Improvement
VII. SF-12 Physical health related General health (GH)
Physical functioning (PF)
Role physical (RP)
Body pain (BP)
Mental health related

Vitality (VT)

Social functioning (SF)

Role emotional (RE)

Mental health (MH)